Phibro Animal Health Corp (PAHC) insider trading

Every open-market stock purchase and sale by Phibro Animal Health Corp executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Company insiders bought $318K over the last 12 months (1 buy).
  • Company insiders sold $28.1M over the last 12 months (30 sales).
  • Last company insider buy: E Thomas Corcoran (Board member), $318K, 5 months ago.

Last 12 months: insiders bought $318K (1 buy) and sold $28.1M (30 sales). Last close $38.88 on Oct 30, 2026.

Recent PAHC insider trades

DateInsiderTradeValue
Aug 6, 2026Larry Lee Miller (COO)Bought (not open market)—
Aug 6, 2026Glenn David (CFO)Bought (not open market)—
Aug 6, 2026Patrick Rodriguez (VP)Bought (not open market)—
Aug 6, 2026Daniel M Bendheim (CEO)Bought (not open market)—
Aug 6, 2026Larry Lee Miller (COO)Bought (not open market)—
Aug 6, 2026Glenn David (CFO)Bought (not open market)—
Aug 6, 2026Jack Bendheim (Chair)Bought (not open market)—
Aug 6, 2026Lisa Ann Escudero (Officer)Bought (not open market)—
Aug 6, 2026Jonathan BENDHEIM (Director)Bought (not open market)—
Aug 6, 2026Judith Weinstein (Officer)Bought (not open market)—
Aug 4, 2026Jack Bendheim (Chair)Sold (not open market)$84.3K
Aug 4, 2026Glenn David (CFO)Sold (not open market)$30.7K
Aug 4, 2026Larry Lee Miller (COO)Sold (not open market)$23.2K
Aug 4, 2026Daniel M Bendheim (CEO)Sold (not open market)$17.8K
Aug 4, 2026Judith Weinstein (Officer)Sold (not open market)$17.3K
Aug 4, 2026Lisa Ann Escudero (Officer)Sold (not open market)$9.7K
Jul 1, 2026Daniel M Bendheim (CEO)Bought (not open market)—
May 29, 2026E Thomas Corcoran (Director)Bought$318K
May 7, 2026Jack Bendheim (CEO)Sold$99.8K
May 7, 2026Jack Bendheim (CEO)Sold$64.2K
May 7, 2026Jack Bendheim (CEO)Sold$55.5K
May 6, 2026Jack Bendheim (CEO)Sold$322K
May 6, 2026Jack Bendheim (CEO)Sold$81.7K
May 5, 2026Jack Bendheim (CEO)Sold$349K
May 5, 2026Jack Bendheim (CEO)Sold$43.7K

Who's trading PAHC

Get free alerts when an insider at Phibro Animal Health Corp files a new trade →